You are here

  • Home
  • Archive
  • Volume 3, Issue 2
  • Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients

Article metrics

Article menu

Download PDFPDF

Vasculitis
Original article
Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients

 

Online download statistics by month:

Online download statistics by month: December 2017 to March 2024

AbstractFullPdf
Dec 2017484815
Jan 2018939473
Feb 2018454434
Mar 2018717215
Apr 201828299
May 201835367
Jun 201827282
Jul 2018353511
Aug 2018454516
Sep 2018252510
Oct 201816163
Nov 201852514
Dec 201826268
Jan 201920205
Feb 2019272711
Mar 201928257
Apr 2019202011
May 2019262615
Jun 201918188
Jul 201919198
Aug 201920187
Sep 201912123
Oct 2019363414
Nov 201928280
Dec 201923218
Jan 202034335
Feb 202027263
Mar 202019189
Apr 2020212152
May 2020252523
Jun 2020131329
Jul 2020222254
Aug 2020121244
Sep 2020353334
Oct 2020302424
Nov 2020221614
Dec 2020272012
Jan 2021212119
Feb 2021151414
Mar 202115158
Apr 2021181717
May 202111118
Jun 202112127
Jul 2021191815
Aug 202110108
Sep 202123205
Oct 2021222119
Nov 2021181719
Dec 202112116
Jan 202210113
Feb 202214156
Mar 2022202717
Apr 202221229
May 2022313613
Jun 202234358
Jul 20221093
Aug 202236337
Sep 202226248
Oct 2022222117
Nov 202217168
Dec 202291013
Jan 2023192210
Feb 202329293
Mar 2023292519
Apr 2023161611
May 2023191912
Jun 202319176
Jul 202314147
Aug 202310103
Sep 202315157
Oct 202314127
Nov 202314116
Dec 202327275
Jan 2024252114
Feb 2024373713
Mar 2024171743
Total186018181030